Moreover, the authors proposed that unexplained hyperglycemia, increased insulin requirements, and the abrupt decrease in C-peptide are markers indicating the sudden loss of islet graft function, and they can contribute to the diagnosis of islet rejection. The gene discussed is INS; the disease is Hyperglycemia.